BOLT vs CSGP · rev $7.7M vs P/E 484, rev $2.74B
Bolt Biotherapeutics (BOLT) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
BOLT currently screens at market cap $11.3M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the BOLT and CSGP stock pages for the full models.
Not investment advice.